ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 63 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 590.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,260,000 | +25.6% | 708,778 | +15.8% | 0.00% | 0.0% |
| Q3 2016 | $2,596,000 | +84.4% | 612,231 | +4.3% | 0.00% | – |
| Q2 2016 | $1,408,000 | +9.5% | 586,720 | +114.4% | 0.00% | – |
| Q1 2016 | $1,286,000 | +16.0% | 273,653 | -3.0% | 0.00% | – |
| Q4 2015 | $1,109,000 | +4.4% | 282,096 | +2.8% | 0.00% | – |
| Q3 2015 | $1,062,000 | -16.4% | 274,301 | -0.7% | 0.00% | – |
| Q2 2015 | $1,271,000 | – | 276,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |